Just a moment…

Just a moment… Enable JavaScript and cookies to continue This request seems a bit unusual, so we need to confirm that you’re human. Please press and hold the button until

Bioengineers shed light on dosing challenges for cancer immunotherapy

A team of Rice University bioengineers has developed a mathematical model that clarifies why interleukin-12 (IL-12) — a potent immune-boosting protein that holds promise for cancer treatment — loses effectiveness

Francis Collins on Supporting NIH and Finding Common Ground

The Host Julie Rovner KFF Health News @jrovner Read Julie’s stories. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health policy news podcast, “What the